Risk for estrogen-dependent diseases in relation to phthalate exposure and polymorphisms of CYP17A1 and estrogen receptor genes

article OA: closed CC0 ⤵ 15 in-corpus citations
AI-generated summary by gemini-2.5-flash-lite+body, 2026-06-07

Phthalate exposure was higher in leiomyoma patients, and combined ESR1 and CYP17A1 polymorphisms significantly increased leiomyoma risk, suggesting gene-environment interactions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

This study investigated whether urinary phthalate metabolite exposure and genetic polymorphisms in estrogen-related genes (CYP17A1, ESR1, and ESR2) were associated with estrogen-dependent disease risk, using 44 patients with endometriosis or adenomyosis, 36 patients with leiomyoma, and 69 healthy controls recruited in Taiwan (2005–2007). Urinary phthalate metabolites (seven monoesters) were measured by LC-MS/MS, and genotypes were determined from peripheral lymphocyte DNA. Compared with controls, leiomyoma patients had significantly higher urinary ΣMEHP, MnBP, and MEP, while endometriosis/adenomyosis patients had only a marginal increase in urinary MEHP; additionally, individuals homozygous for ESR1 rs2234693 C and CYP17A1 rs743572 C had a significantly increased risk of leiomyoma after covariate adjustment. The paper does not explicitly discuss limitations in the abstract beyond its relatively small sample size and marginal associations. This paper is centrally about adenomyosis and endometriosis in the sense that it includes patients with endometriosis or adenomyosis as a primary comparison group for phthalate exposure and estrogen-pathway gene polymorphisms.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Evidence has shown that polymorphisms of various genes known to be involved in estrogen biosynthesis and function are associated with estrogen-dependent diseases (EDDs). These genes include CYP17A1, estrogen receptor 1 (ESR1), and 2 (ESR2). Phthalates are considered estrogenic endocrine disruptors, and recent research has suggested that they may act as a risk factor for EDDs. However, extremely few studies have assessed the effects of gene-environment interaction on these diseases. We recruited 44 patients with endometriosis or adenomyosis, 36 patients with leiomyoma, and 69 healthy controls from a medical center in Taiwan between 2005 and 2007. Urine samples were collected and analyzed for seven phthalate metabolites using liquid chromatography tandem mass spectrometry. Peripheral lymphocytes were used for DNA extraction to determine the genotype of CYP17A1, ESR1, and ESR2. Compared to controls, patients with leiomyoma had significantly higher levels of total urinary mono-ethylhexyl phthalate (ΣMEHP) (52.1 vs. 29.6 μg/g creatinine, p = 0.040), mono-n-butyl phthalate (MnBP) (75.4 vs. 51.3 μg/g creatinine, p = 0.019), and monoethyl phthalate (MEP) (103.7 vs. 59.3 μg/g creatinine, p = 0.031). In contrast, patients with endometriosis or adenomyosis showed a marginally increased level of urinary MEHP only. Subjects who were homozygous for both the ESR1 C allele (rs2234693) and CYP17A1 C allele (rs743572) showed a significantly increased risk for leiomyoma (OR = 19.8; 95 % CI, 1.70; 231.5; p = 0.017) relative to subjects with other genotypes of ESR1 and CYP17A1. These results were obtained after adjusting for age, cigarette smoking, MEHP level, GSTM1 genotype and other covariates. Our results suggested that both CYP17A1 and ESR1 polymorphisms may modulate the effects of phthalate exposure on the development of leiomyoma.
Full text 14,631 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Evidence has shown that polymorphisms of various genes known to be involved in estrogen biosynthesis and function are associated with estrogen-dependent diseases (EDDs). These genes include CYP17A1, estrogen receptor 1 (ESR1), and 2 (ESR2). Phthalates are considered estrogenic endocrine disruptors, and recent research has suggested that they may act as a risk factor for EDDs. However, extremely few studies have assessed the effects of gene–environment interaction on these diseases. We recruited 44 patients with endometriosis or adenomyosis, 36 patients with leiomyoma, and 69 healthy controls from a medical center in Taiwan between 2005 and 2007. Urine samples were collected and analyzed for seven phthalate metabolites using liquid chromatography tandem mass spectrometry. Peripheral lymphocytes were used for DNA extraction to determine the genotype of CYP17A1, ESR1, and ESR2. Compared to controls, patients with leiomyoma had significantly higher levels of total urinary mono-ethylhexyl phthalate (ΣMEHP) (52.1 vs. 29.6 μg/g creatinine, p = 0.040), mono-n-butyl phthalate (MnBP) (75.4 vs. 51.3 μg/g creatinine, p = 0.019), and monoethyl phthalate (MEP) (103.7 vs. 59.3 μg/g creatinine, p = 0.031). In contrast, patients with endometriosis or adenomyosis showed a marginally increased level of urinary MEHP only. Subjects who were homozygous for both the ESR1 C allele (rs2234693) and CYP17A1 C allele (rs743572) showed a significantly increased risk for leiomyoma (OR = 19.8; 95 % CI, 1.70; 231.5; p = 0.017) relative to subjects with other genotypes of ESR1 and CYP17A1. These results were obtained after adjusting for age, cigarette smoking, MEHP level, GSTM1 genotype and other covariates. Our results suggested that both CYP17A1 and ESR1 polymorphisms may modulate the effects of phthalate exposure on the development of leiomyoma. Similar content being viewed by others

References

Al-Hendy A, Salama S (2006) Gene therapy and uterine leiomyoma: a review. Hum Reprod Update 12:385–400 Amant F, Dorfling CM, de Brabanter J, Vandewalle J, Vergote I, Lindeque BG, van Rensburg EJ (2004) A possible role of the cytochrome P450c17alpha gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot study. Acta Obstet Gynecol Scand 83:234–239 Arvanitis DA, Koumantakis GE, Goumenou AG, Matalliotakis IM, Koumantakis EE, Spandidos DA (2003) CYP1A1, CYP19, and GSTM1 polymorphisms increase the risk of endometriosis. Fertil Steril 79(Suppl 1):702–709 Asghar T, Yoshida S, Nakago S, Morizane M, Ohara N, Motoyama S, Kennedy S, Barlow D, Maruo T (2005) Lack of association between endometriosis and the CYP17 MspA1 polymorphism in UK and Japanese populations. Gynecol Endocrinol 20:59–63 Bischoff F, Simpson JL (2004) Genetics of endometriosis: heritability and candidate genes. Best Pract Res Clin Obstet Gynaecol 18:219–232 Bulun SE (2009) Endometriosis. New Engl J Med 15:268–279 Cai LY, Izumi S, Suzuki T, Goya K, Nakamura E, Sugiyama T, Kobayashi H (2011) Dioxins in ascites and serum of women with endometriosis: a pilot study. Hum Reprod 26:117–126 Carey AH, Waterworth D, Patel K, White D, Little J, Novelli P, Franks S, Williamson R (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3:1873–1876 Chan S (2002) A review of selective estrogen receptor modulators in the treatment of breast and endometrial cancer. Semin Oncol 29(3 Suppl 11):129–133 Chan PK, Meek ME (1994) Di-n-butyl phthalate: Evaluation of risks to health from environmental exposure in Canada. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 12:257–268 Chen ML, Chen JS, Tang CL, Mao IF (2008) The internal exposure of Taiwanese to phthalate—an evidence of intensive use of plastic materials. Environ Int 34:79–85 Cobellis L, Latini G, De Felice C, Razzi S, Paris I, Ruggieri F, Mazzeo P, Petraglia F (2003) High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis. Hum Reprod 18:1512–1515 Duty SM, Ackerman RM, Calafat AM, Hauser R (2005) Personal care product use predicts urinary concentrations of some phthalate monoesters. Environ Health Perspect 113:1530–1535 Eskenazi B, Mocarelli P, Warner M, Samuels S, Vercellini P, Olive D, Needham LL, Patterson DG Jr, Brambilla P, Gavoni N, Casalini S, Panazza S, Turner W, Gerthoux PM (2002) Serum dioxin concentrations and endometriosis: a cohort study in Seveso, Italy. Environ Health Perspect 110:629–634 Eskenazi B, Warner M, Samuels S, Young J, Gerthoux PM, Needham L, Patterson D, Olive D, Gavoni N, Vercellini P, Mocarelli P (2007) Serum dioxin concentrations and risk of uterine leiomyoma in the Seveso Women’s Health Study. Am J Epidemiol 166:79–87 Feigelson HS, Shames LS, Pike MC, Coetzee GA, Stanczyk FZ, Henderson BE (1998) Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res 58:585–587 Flake GP, Andersen J, Dixon D (2003) Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 111:1037–1054 Georgiou I, Syrrou M, Bouba I, Dalkalitsis N, Paschopoulos M, Navrozoglou I, Lolis D (1999) Association of estrogen receptor gene polymorphisms with endometriosis. Fertil Steril 72:164–166 Giudice L, Kao L (2004) Endometriosis. Lancet 364:1789–1799 Govindan S, Shaik NA, Vedicherla B, Kodati V, Rao KP, Hasan Q (2009) Estrogen receptor-alpha gene (T/C) Pvu II polymorphism in endometriosis and uterine fibroids. Dis Markers 26:149–154 Guo SW (2005) Glutathione S-transferases M1/T1 gene polymorphisms and endometriosis: a meta-analysis of genetic association studies. Mol Hum Reprod 11:729–743 Guo Y, Alomirah H, Cho HS, Minh TB, Mohd MA, Nakata H, Kannan K (2011) Occurrence of phthalate metabolites in human urine from several Asian countries. Environ Sci Technol 45:3138–3144 Harris CA, Henttu P, Parker MG, Sumpter JP (1997) The estrogenic activity of phthalate esters in vitro. Environ Health Perspect 105:802–811 Houlihan J, Brody C, Schwan B (2002) Not too pretty: phthalates, beauty products and the FDA. Environmental Working Group Hsieh YY, Chang CC, Tsai FJ, Lin CC, Tsai CH (2005) Estrogen receptor alpha dinucleotide repeat and cytochrome P450c17alpha gene polymorphisms are associated with susceptibility to endometriosis. Fertil Steril 83:567–572 Hsieh YY, Wang YK, Chang CC, Lin CS (2007) Estrogen receptor alpha-351 XbaI*G and −397 PvuII*C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma. Mol Hum Reprod 13:117–122 Hsu JF, Lee CC, Su HJ, Chen HL, Yang SY, Liao PC (2009) Evaluation of background persistent organic pollutant levels in human from Taiwan: polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls. Environ Int 35:33–42 Huang PC, Kuo PL, Chou YY, Lin SJ, Lee CC (2009) Association between prenatal exposure to phthalates and the health of newborns. Environ Int 35:14–20 Huang PC, Tsai EM, Li WF, Liao PC, Chung MC, Wang YH, Wang SL (2010) Association between phthalate exposure and glutathione S-transferase M1 polymorphism in adenomyosis, leiomyoma and endometriosis. Hum Reprod 25:986–994 Huang PC, Laou SH, Ho IK, Chiang HC, Huang HI, Wang SL (2012) Phthalate exposure and endocrinal effects: an epidemiological review. J Food Drug Anal 20:719–733 Itoh H, Iwasaki M, Hanaoka T, Sasaki H, Tanaka T, Tsugane S (2009) Urinary phthalate monoesters and endometriosis in infertile Japanese women. Sci Total Environ 15:37–42 Jackson LW, Schisterman EF, Dey-Rao R, Browne R, Armstrong D (2005) Oxidative stress and endometriosis. Hum Reprod 20:2014–2020 Jin Q, Sun Z, Li Y (2008) Estrogenic activities of di-2-ethylhexyl phthalate. Front Med China 2:303–308 Juo SH, Wang TN, Lee JN, Wu MT, Long CY, Tsai EM (2006) CYP17, CYP1A1 and COMT polymorphisms and the risk of adenomyosis and endometriosis in Taiwanese women. Hum Reprod 21:1498–1502 Just AC, Adibi JJ, Rundle AG, Calafat AM, Camann DE, Hauser R, Silva MJ, Whyatt RM (2010) Urinary and air phthalate concentrations and self-reported use of personal care products among minority pregnant women in New York city. J Expo Sci Environ Epidemiol 20:625–633 Kado N, Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Tsukamoto K, Hasegawa G, Nakamura N, Yoshikawa T, Honjo H (2002) Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women. Hum Reprod 17:897–902 Kitawaki J (2006) Adenomyosis: the pathophysiology of an oestrogen-dependent disease. Best Pract Res Clin Obstet Gynaecol 20:493–502 Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Kado N, Tsukamoto K, Hasegawa G, Nakamura N, Honjo H (2001) Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. Hum Reprod 16:51–55 Koninckx PR, Braet P, Kennedy SH, Barlow DH (1994) Dioxin pollution and endometriosis in Belgium. Hum Reprod 9:1001–1002 Koo JW, Parham F, Kohn MC, Masten SA, Brock JW, Needham LL, Portier CJ (2002) The association between biomarker-based exposure estimates for phthalates and demographic factors in a human reference population. Environ Health Perspect 110:405–410 Lin LC, Wang SL, Chang YC, Huang PC, Cheng JT, Su PH, Liao PC (2011a) Associations between maternal phthalate exposure and cord sex hormones in human infants. Chemosphere 83:1192–1199 Lin S, Ku HY, Su PH, Chen JW, Huang PC, Angerer J, Wang SL (2011b) Phthalate exposure in pregnant women and their children in Central Taiwan. Chemosphere 82:947–955 Ma M, Kondo T, Ban S, Umemura T, Kurahashi N, Takeda M, Kishi R (2006) Exposure of prepubertal female rats to inhaled di(2-ethylhexyl)phthalate affects the onset of puberty and postpubertal reproductive functions. Toxicol Sci 93:164–171 Mizunuma H, Hosoi T, Okano H, Soda M, Tokizawa T, Kagami I, Miyamoto S, Ibuki Y, Inoue S, Shiraki M, Ouchi Y (1997) Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women. Bone 21:379–383 Moore NP (2000) The oestrogenic potential of the phthalate esters. Reprod Toxicol 14:183–192 Okubo T, Suzuki T, Yokoyama Y, Kano K, Kano I (2003) Estimation of estrogenic and anti-estrogenic activities of some phthalate diesters and monoesters by MCF-7 cell proliferation assay in vitro. Biol Pharm Bull 26:1219–1224 Othman EE, Al-Hendy A (2008) Molecular genetics and racial disparities of uterine leiomyomas. Best Pract Res Clin Obstet Gynaecol 22:589–601 Pauwels A, Schepens PJ, D’Hooghe T, Delbeke L, Dhont M, Brouwer A, Weyler J (2001) The risks of endometriosis and exposure to dioxins and polychlorinated biphenyls: a case-controlled study of infertile women. Hum Reprod 16:2050–2055 Reddy BS, Rozati R, Reddy S, Kodampur S, Reddy P, Reddy R (2006) High plasma concentrations of polychlorinated biphenyls and phthalate esters in women with endometriosis: a prospective case control study. Fertil Steril 85:775–779 Romero-Franco M, Hernández-Ramírez RU, Calafat AM, Cebrián ME, Needham LL, Teitelbaum S, Wolff MS, López-Carrillo L (2011) Personal care product use and urinary levels of phthalate metabolites in Mexican women. Environ Int 37:867–871 Rosa FE, Canevari Rde A, Ambrosio EP, Ramos Cirilo PD, Pontes A, Rainho CA, Rogatto SR (2008) Polymorphisms of CYP17A1, CYP19, and androgen in Brazilian women with uterine leiomyomas. Clin Chem Lab Med 46:814–823 Small CM, Marcus M, Sherman SL, Sullivan AK, Manatunga AK, Feigelson HS (2005) CYP17 genotype predicts serum hormone levels among pre-menopausal women. Hum Reprod 20:2162–2167 Takeuchi S, Iida M, Kobayashi S, Jin K, Matsuda T, Kojima H (2005) Differential effects of phthalate esters on transcriptional activities via human estrogen receptors alpha and beta, and androgen receptor. Toxicology 210:223–233 Vercellini P, Viganò P, Somigliana E, Daguati R, Abbiati A, Fedele L (2006) Adenomyosis: epidemiological factors. Best Pract Res Clin Endoc Metab 20:465–477 Viganò P, Parazzini F, Somigliana E, Vercellini P (2004) Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol 18:177–200 Viganò P, Somigliana E, Vignali M, Busacca M, Blasio AM (2007) Genetics of endometriosis: current status and prospects. Front Biosci 12:3247–3255 Wang Z, Yoshida S, Negoro K, Kennedy S, Barlow D, Maruo T (2004) Polymorphisms in the estrogen receptor beta gene but not estrogen receptor alpha gene affect the risk of developing endometriosis in a Japanese population. Fertil Steril 81:1650–1656 Weuve J, Hauser R, Calafat AM, Missmer SA, Wise LA (2010) Association of exposure to phthalates with endometriosis and uterine leiomyomata: findings from NHANES, 1999–2004. Environ Health Perspect 118:825–832 Yin PH, Lee HC, Chau GY, Liu TY, Liu HC, Lui WY, Chi CW (2004) Polymorphisms of estrogen-metabolizing genes and risk of hepatocellular carcinoma in Taiwan females. Cancer Lett 212:195–201 Zhai XD, Ye Y, Yang Y, Wang Z, Mo YN (2009) No association between estrogen receptor beta polymorphisms and uterine leiomyoma. DNA Cell Biol 28:633–636 Zhao Y, Zhang W, Wang S (2008) The expression of estrogen receptor isoforms alpha, beta and insulin-like growth factor-I in uterine leiomyoma. Gynecol Endocrinol 24:549–554 Acknowledgments We are also greatly indebted to the gynecologists of the Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, and to our colleagues, especially for Ms. H-Y Chen and Ms. P-J Lin, at the National Health Research Institute, Miaoli, Taiwan. These two groups assisted us with subject recruitment and sample collection. We also thank Ms. M-C Chung and Mr. J-H Lu for their technical assistance of genetic polymorphism. Funding sources We are grateful for financial support from the National Health Research Institute (grant nos.: EO-095-PP-09, EO-096-PP-09 and EH-102-PP-02) and National Science Council, Taiwan [grant number; NSC 102-2632-B-037-001-MY3]. Author information Authors and Affiliations Corresponding authors Additional information Responsible editor: Philippe Garrigues Electronic supplementary material Below is the link to the electronic supplementary material. ESM 1 (download DOC ) (DOC 68 kb) Rights and permissions About this article Cite this article Huang, PC., Li, WF., Liao, PC. et al. Risk for estrogen-dependent diseases in relation to phthalate exposure and polymorphisms of CYP17A1 and estrogen receptor genes. Environ Sci Pollut Res 21, 13964–13973 (2014). https://doi.org/10.1007/s11356-014-3260-6 Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s11356-014-3260-6

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

MeSH descriptors

Estrogen Receptor alpha Estrogen Receptor beta Estrogens Phthalic Acids Polymorphism, Genetic Steroid 17-alpha-Hydroxylase Adult Aged Case-Control Studies Environmental Pollutants Environmental Pollutants Estrogen Receptor alpha Estrogen Receptor alpha Estrogen Receptor beta Estrogen Receptor beta Estrogens Female Gene Expression Regulation Genotype Humans

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (64)

Cited by (16)

Source provenance

europepmc
last seen: 2026-09-04T06:17:57.233406+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:18:22.440000+00:00
License: CC0 · commercial use OK